Stories about Central nervous system
- more
Technische Universität München
Coronavirus: door opener facilates cell entry
moreZentiva Reinforces Its Presence In Greece To Better Serve Greek People
moreSTADA expands specialty footprint through acquisition of innovative therapy for treating advanced Parkinson's disease
One documentmoreSTADA's US partner Supernus submits NDA for apomorphine infusion pump
One documentmoreNew MAVENCLAD® Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting Highlight Rapid Onset of Action and Compelling Post-Approval Safety
moreFinal Phase II Results for UCB's Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) Published in Blood Advances
moreMerck to Showcase New Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting, Furthering Innovation in Multiple Sclerosis
moreEthypharm's UK manufacturing site passes its 1st U.S. FDA inspection
moreUCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer's Disease
moreUCB Half Year Report 2020
moreThe International Osteoporosis Foundation (IOF)
New Capture the Fracture® partnership aims for 25% reduction in the incidence of hip and vertebral fractures due to osteoporosis by 2025
moreUCB Acquires Engage Therapeutics: Staccato® Alprazolam - A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy
moreMerck and Twitch Join Forces on World Multiple Sclerosis Day to Connect People Living With MS
moreUCB's General Meeting of Shareholders
moreUCB Completes the Acquisition of Ra Pharmaceuticals - to Deliver Differentiated Therapies to Patients
moreTechnische Universität München
Major project for Munich neurosciences
moreUCB Presents Final Results from Phase II Study of Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) at 2019 ASH Annual Meeting
moreUCB Agrees to Acquire Ra Pharmaceuticals: Joining Forces to Improve Treatment Options for People Living With Myasthenia Gravis and Other Rare Diseases
moreMerck to Showcase New Data Across MS Portfolio at EAN 2019
moreExperts Discuss: 'Social Egg Freezing' - Does It Alleviate or Increase the Pressure Among Women to Have a Baby Early?
moreMerck Pioneers New Efforts to See MS From the Inside Out
moreMerck to Present New Data on Mavenclad®, Rebif® and the Investigational Therapy Evobrutinib at the AAN Annual Meeting 2019
moreFDA Approves MAVENCLAD® (Cladribine) Tablets as First and Only Short-Course Oral Treatment for Relapsing-Remitting and Active Secondary Progressive Multiple Sclerosis
moreMAVENCLAD® (Cladribine Tablets) Approved As The First Short-Course Oral Treatment for Relapsing Remitting Multiple Sclerosis in Switzerland
moreNORGINE B.V. and KOREA PHARMA CO., LTD.
NORGINE B.V. and KOREA PHARMA CO., LTD. Enter Into Exclusive Licence Agreement for the Commercialisation of PLENVU® in the Republic of Korea
moreUCB Accelerates Anti-FcRn Rozanolixizumab in Myasthenia Gravis Into Confirmatory Development Phase
moreGlobal Survey and Documentary Film Expose Emotional Impact of Multiple Sclerosis
moreSatiety in 3D
moreZambon Expands in Europe Acquiring Nigaard
more
12Next